# DERMALIX Efficacy on Diabetic Foot Ulcers

> **NCT03136822** · NA · COMPLETED · sponsor: **Dermis Pharma** · enrollment: 48 (actual)

## Conditions studied

- Diabetic Foot
- Diabetic Foot Ulcer

## Interventions

- **OTHER:** Standard Dressing
- **DEVICE:** DERMALIX

## Key facts

- **NCT ID:** NCT03136822
- **Lead sponsor:** Dermis Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-26
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-08-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136822, "DERMALIX Efficacy on Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03136822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*